Arthroplasty Outcomes in Immune Checkpoint Inhibitor-Treated Patients: A Single Center Series

被引：0

作者：

Elfarra, Yasmine ^{[1
]}

DiCarlo, Edward ^{[2
]}

Vigdorchik, Jonathan ^{[2
]}

Aude, Carlos ^{[3
]}

Ghosh, Nilasha ^{[3
]}

Bass, Anne ^{[3
]}

Chan, Karmela Kim ^{[2
]}

机构：

[1] Weill Cornell, New York, NY USA

[2] Hosp Special Surg, New York, NY USA

[3] Weill Cornell Med, Hosp Special Surg, New York, NY USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1919

引用

页码：3807 / 3809

页数：3

共 50 条

[1] Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor-Treated Patients Reconciling Adjudicated and Coded Outcomes
Kondapalli, Lavanya
Hsia, Judith
Miller, Ronni
Flaig, Thomas W.
Bonaca, Marc P.
JACC: CARDIOONCOLOGY, 2022, 4 (05): : 649 - 656
[2] Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Lee, Pei-Chang
Wu, Chi-Jung
Hung, Ya-Wen
Lee, Chieh Ju
Chi, Chen-Ta
Lee, I-Cheng
Yu-Lun, Kuo
Chou, Shih-Hsuan
Luo, Jiing-Chyuan
Hou, Ming-Chih
Huang, Yi-Hsiang
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
[3] Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Lee, Pei-Chang
Chao, Yee
Chen, Ming-Huang
Lan, Keng-Hsin
Lee, I-Cheng
Hou, Ming-Chih
Huang, Yi-Hsiang
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[4] Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
Lee, Pei-Chang
Chao, Yee
Chen, Ming-Huang
Lan, Keng-Hsin
Lee, Chieh-Ju
Lee, I-Cheng
Chen, San-Chi
Hou, Ming-Chih
Huang, Yi-Hsiang
CANCERS, 2020, 12 (01)
[5] Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study
Masaki, Kou
Miyazaki, Motoyasu
Kakimoto, Hideki
Fukiage, Yuma
Fukue, Haruka
Nakashima, Akio
Imakyure, Osamu
Sparreboom, Alex
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
[6] ATRIAL ARRHYTHMIA INCIDENCE AND OUTCOMES IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY
Khan, Daniel
Mohammed, Norhan
Herrmann, Joerg
Tan, Nicholas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2381 - 2381
[7] Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
Nizam, Amanda
Rader, Ryan K.
Tzeng, Alice
Wei, Wei
Sheng, Iris Yeong-Fung
Martin, Allison
Wee, Christopher E.
Gilligan, Timothy D.
Gupta, Shilpa
Ornstein, Moshe C.
CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 368 - 379
[8] Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
Zhu, Chengpei
Zhang, Chenchen
Wang, Shanshan
Xun, Ziyu
Zhang, Dongya
Lan, Zhou
Zhang, Longhao
Chao, Jiashuo
Liang, Yajun
Pu, Zilun
Ning, Cong
Sang, Xinting
Yang, Xiaobo
Wang, Hanping
Jiang, Xianzhi
Zhao, Haitao
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
[9] Osteonecrosis in protease inhibitor-treated patients
Bonfanti, P
Gabbuti, A
Carradori, S
Pusterla, L
Parazzini, F
Landonio, S
Quirino, T
ORTHOPEDICS, 2001, 24 (03) : 271 - 272
[10] Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival
Berner, Fiamma
Niederer, Rebekka
Luimstra, Jolien J.
Pop, Oltin Tiberiu
Jochum, Ann-Kristin
Purde, Mette-Triin
Ali, Omar Hasan
Bomze, David
Bauer, Jens
Freudenmann, Lena Katharina
Marcu, Ana
Wolfschmitt, Eva-Maria
Haen, Sebastian
Gross, Thorben
Dubbelaar, Marissa Lisa
Abdou, Marie-Therese
Baumgaertner, Petra
Appenzeller, Christina
Cicin-Sain, Caroline
Lenz, Tobias
Speiser, Daniel E.
Ludewig, Burkhard
Driessen, Christoph
Jorger, Markus
Fruh, Martin
Jochum, Wolfram
Cozzio, Antonio
Rammensee, Hans-Georg
Walz, Juliane
Neefjes, Jacques
Flatz, Lukas
ONCOIMMUNOLOGY, 2021, 10 (01):

← 1 2 3 4 5 →